𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen replacement therapy in women with a history of proliferative breast disease

✍ Scribed by William D. Dupont; David L. Page; Fritz F. Parl; W. Dale Plummer Jr.; Peggy A. Schuyler; Masako Kasami; Roy A. Jensen

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
86 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Dr. Dupont has accepted honoraria for presenting papers at professional meetings from pharmaceutical firms that market hormonal replacement therapy. On three occasions in his career he has been a consultant for Wyeth-Ayerst Pharmaceuticals.

The authors thank Marcia G. Freudenthal, Cheryl D. Sharpe, Julia F. Smith, and Kay B. Covington for their skilled and dedicated pursuit of follow-up information; Drs. Steven J. Schultenover, Barrett Bartley, Richard R. Oldham, and more than 60 Nashville surgeons and the staffs of the tumor registries and record departments of the three Nashville hospitals for their cooperation and aid in patient follow-up; the thousands of women who have participated in our studies; and Dr. Susan M. Dupont for her helpful suggestions.

πŸ“œ SIMILAR VOLUMES

Hormone replacement therapy and the risk
Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening
✍ Ingemar Persson; Erik Thurfjell; Reinhold BergstrΓΆm; Lars Holmberg πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 37 KB πŸ‘ 2 views

There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer

Correction of neutrophil chemotaxis defe
Correction of neutrophil chemotaxis defect in patients with gaucher disease by low-dose enzyme replacement therapy
✍ Dr. A. Zimran; A. Abrahamov; M. Aker; Y. Matzner πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 192 KB πŸ‘ 1 views

We have recently described a chemotactic defect in severely afflicted Gaucher disease patients. Two of the patients were treated with low-dose intravenous enzyme replacement (Ceredase). Marked improvement in their hematological status, organomegaly, and growth was observed. In addition, their chemot

A randomized controlled trial of the eff
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer
✍ A.J. Cunningham; C.V.I. Edmonds; G.P. Jenkins; H. Pollack; G.A. Lockwood; D. War πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

In order to test the effect of a psychological intervention on survival from cancer, 66 women with metastatic breast cancer, all receiving standard medical care, were randomly assigned into two groups; one group (n = 30) attended the psychological intervention, consisting of 35 weekly, 2 h sessions

Prevalence of germline truncating mutati
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor
✍ Timothy D. Shafman; Seth Levitz; Asa J. Nixon; Lor-Anne Gibans; Kim E. Nichols; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Patients treated with conservative surgery and radiation therapy for early-stage breast cancer develop a contralateral breast cancer at a rate of approximately 0.75% per year. Ataxia-telangiectasia (AT) is an autosomal recessive disease that is characterized by increased sensitivity to ionizing radi